Firmenbeschreibung
Merck & Co. Inc. ist ein forschungsorientiertes, globales Pharmaunternehmen, das ein breites Sortiment an neuartigen Medikamenten, Impfstoffen und biologischen Therapeutika erforscht, entwickelt, produziert und vermarktet. Das Angebot richtet sich vorwiegend an Krankenhäuser, Apotheken, Einzelhändler, Versicherungen, Regierungsverwaltungen oder institutionelle Einrichtungen aus dem Gesundheitswesen. Des Weiteren bietet Merck & Co. nicht-verschreibungspflichtige Medikamente, Produkte für die Fußpflege und Sonnenschutzmittel sowie Gesundheitsprodukte für Tiere an. Dabei bedient sich das Unternehmen der Biotechnologie, der Genforschung und der Gentherapie. Schwerpunkte sind die Behandlung von Allergien, Atemwegserkrankungen, Infektionskrankheiten, Krebs, Herz- und Kreislauferkrankungen, Erkrankungen des zentralen Nervensystems sowie Hautkrankheiten.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Freefloat (83.84%),The Vanguard Group, Inc. (8.36%),BlackRock, Inc. (7.8%) |
| sharesOutstanding: | 2535395974.0000 |
| ceo: | Robert M. Davis |
| board: | Caroline Litchfield, Cristal N. Downing, Dave Williams, Dr. Dean Y. Li, Frank Clyburn, Jennifer Zachary, Julie L. Gerberding, Michael A. Klobuchar, Richard R. DeLuca Jr., Sanat Chattopadhyay, Steven C. Mizell |
| supervisoryBoard: | Kenneth C. Frazier, Christine E. Seidman, M.D., Inge Thulin, Kathy J. Warden, Mary Ellen Coe, Pamela J. Craig, Patricia F. Russo, Paul B. Rothman, M.D., Peter C. Wendell, Risa J. Lavizzo-Mourey, M.D., Robert M. Davis, Stephen L. Mayo, Thomas H. Glocer |
| countryID: | 20 |
| freeFloat: | 83.8400 |
| faceValue: | 0.5000 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Teri Loxam |
| phone: | +1-908-740-1986 |
| email: | investor_relations@merck.com |
| irWebSite: | https://www.merck.com/investor-relations/ |
Adresse
| street: | 2000 Galloping Hill Road |
| city: | Kenilworth, New Jersey 07033, USA |
| phone: | +1-908-740-4000 |
| webSite: | www.merck.com |
Finanzen (kurz)
| year: | 2020 | cash: | 8062.0000 |
| balanceSheetTotal: | 91588.0000 | liabilities: | 66184.0000 |
| totalShareholdersEquity: | 25404.0000 | sales: | 47994.0000 |
| incomeBeforeTaxes: | 8791.0000 | netIncome: | 7067.0000 |
| cashFlow: | -1769.0000 | employees: | 74000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2021 | cash: | 8096.0000 |
| balanceSheetTotal: | 105694.0000 | liabilities: | 67437.0000 |
| totalShareholdersEquity: | 38257.0000 | sales: | 48704.0000 |
| incomeBeforeTaxes: | 13879.0000 | netIncome: | 13049.0000 |
| cashFlow: | 14.0000 | employees: | 68000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2022 | cash: | 12694.0000 |
| balanceSheetTotal: | 109160.0000 | liabilities: | 63102.0000 |
| totalShareholdersEquity: | 46058.0000 | sales: | 59283.0000 |
| incomeBeforeTaxes: | 16444.0000 | netIncome: | 14519.0000 |
| cashFlow: | 4606.0000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
Finanzen (kurz)
| year: | 2020 |
| cash: | 8062.0000 |
| balanceSheetTotal: | 91588.0000 |
| liabilities: | 66184.0000 |
| totalShareholdersEquity: | 25404.0000 |
| sales: | 47994.0000 |
| incomeBeforeTaxes: | 8791.0000 |
| netIncome: | 7067.0000 |
| cashFlow: | -1769.0000 |
| employees: | 74000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2021 |
| cash: | 8096.0000 |
| balanceSheetTotal: | 105694.0000 |
| liabilities: | 67437.0000 |
| totalShareholdersEquity: | 38257.0000 |
| sales: | 48704.0000 |
| incomeBeforeTaxes: | 13879.0000 |
| netIncome: | 13049.0000 |
| cashFlow: | 14.0000 |
| employees: | 68000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 12694.0000 |
| balanceSheetTotal: | 109160.0000 |
| liabilities: | 63102.0000 |
| totalShareholdersEquity: | 46058.0000 |
| sales: | 59283.0000 |
| incomeBeforeTaxes: | 16444.0000 |
| netIncome: | 14519.0000 |
| cashFlow: | 4606.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2021 | units: | 1000000 |
| balanceSheetTotal: | 105694.0000 | cash: | 8096.0000 |
| currentAssets: | 30266.0000 | fixedAssets: | 75428.0000 |
| liabilities: | 23872.0000 | totalLiabilitiesEquity: | 105694.0000 |
| provisions: | 3441.0000 | totalShareholdersEquity: | 38257.0000 |
| employees: | 68000 | property: | 19279.0000 |
| intangibleAssets: | 22933.0000 | longTermInvestments: | 370.0000 |
| inventories: | 5953.0000 | accountsReceivable: | 9230.0000 |
| accountsPayable: | 4609.0000 | liabilitiesBanks: | 1768.0000 |
| liabilitiesTotal: | 67437.0000 | longTermDebt: | 30690.0000 |
| shortTermDebt: | 2412.0000 | minorityInterests: | 73.0000 |
| sales: | 48704.0000 | netIncome: | 13049.0000 |
| incomeInterest: | -1341.0000 | investments: | 12245.0000 |
| incomeTaxes: | 1521.0000 | costGoodsSold: | 13626.0000 |
| grossProfit: | 35078.0000 | minorityInterestsProfit: | 13.0000 |
| revenuePerEmployee: | 716235.2941 | cashFlow: | 13122.0000 |
| cashFlowInvesting: | -16421.0000 | cashFlowFinancing: | 3097.0000 |
| cashFlowTotal: | 14.0000 | accountingStandard: | US GAAP |
| equityRatio: | 36.1960 | debtEquityRatio: | 176.2736 |
| liquidityI: | 33.9142 | liquidityII: | 72.5788 |
| netMargin: | 26.7925 | grossMargin: | 72.0228 |
| cashFlowMargin: | 26.9423 | ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 36.2783 |
| preTaxROA: | 13.1313 | roe: | 34.1088 |
| roa: | 12.3460 | netIncomeGrowth: | 84.6470 |
| revenuesGrowth: | 1.4794 | taxExpenseRate: | 10.9590 |
| equityTurnover: | 1.2731 | epsBasic: | 5.1600 |
| epsDiluted: | 5.1400 | epsBasicGrowth: | 84.9462 |
| incomeBeforeTaxes: | 13879.0000 | priceEarningsRatioCompany: | 14.8527 |
| priceCashFlowRatio: | 14.7634 | dividendYield: | 3.4447 |
| bookValuePerShare: | 15.1349 | marketCap: | 193725503563.8400 |
| earningsYield: | 6.7328 | pegRatio: | 0.1748 |
| cashFlowPerShare: | 5.1912 | netAssetsPerShare: | 15.1638 |
| priceBookValueRatio: | 5.0638 | dividendsPerShare: | 2.6400 |
| priceEarningsRatio: | 14.8460 | netEarningsPerShare: | 5.1623 |
| currency: | USD |
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 109160.0000 | cash: | 12694.0000 |
| currentAssets: | 35722.0000 | fixedAssets: | 73438.0000 |
| liabilities: | 24239.0000 | totalLiabilitiesEquity: | 109160.0000 |
| totalShareholdersEquity: | 46058.0000 | property: | 21422.0000 |
| intangibleAssets: | 20269.0000 | longTermInvestments: | 1015.0000 |
| inventories: | 5911.0000 | accountsReceivable: | 9450.0000 |
| accountsPayable: | 4264.0000 | liabilitiesTotal: | 63102.0000 |
| longTermDebt: | 28745.0000 | shortTermDebt: | 1946.0000 |
| minorityInterests: | 67.0000 | sales: | 59283.0000 |
| netIncome: | 14519.0000 | incomeInterest: | 1501.0000 |
| investments: | 13548.0000 | incomeTaxes: | 1918.0000 |
| costGoodsSold: | 17411.0000 | grossProfit: | 41872.0000 |
| minorityInterestsProfit: | 7.0000 | cashFlow: | 19095.0000 |
| cashFlowInvesting: | -4960.0000 | cashFlowFinancing: | -9119.0000 |
| cashFlowTotal: | 4606.0000 | accountingStandard: | US GAAP |
| equityRatio: | 42.1931 | debtEquityRatio: | 137.0055 |
| liquidityI: | 52.3701 | liquidityII: | 91.3569 |
| netMargin: | 24.4910 | grossMargin: | 70.6307 |
| cashFlowMargin: | 32.2099 | ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 35.7028 |
| preTaxROA: | 15.0641 | roe: | 31.5233 |
| roa: | 13.3007 | netIncomeGrowth: | 11.2652 |
| revenuesGrowth: | 21.7210 | taxExpenseRate: | 11.6638 |
| equityTurnover: | 1.2871 | epsBasic: | 5.7300 |
| epsDiluted: | 5.7100 | epsBasicGrowth: | 11.0465 |
| incomeBeforeTaxes: | 16444.0000 | priceEarningsRatioCompany: | 19.3630 |
| priceCashFlowRatio: | 14.7503 | dividendYield: | 2.5237 |
| bookValuePerShare: | 18.1431 | marketCap: | 281656834213.6500 |
| earningsYield: | 5.1645 | pegRatio: | 1.7529 |
| cashFlowPerShare: | 7.5219 | netAssetsPerShare: | 18.1695 |
| priceBookValueRatio: | 6.1153 | dividendsPerShare: | 2.8000 |
| priceEarningsRatio: | 19.3992 | netEarningsPerShare: | 5.7193 |
| currency: | USD |
| year: | 2023 | priceEarningsRatioCompany: | 18.1379 |
| priceCashFlowRatio: | 13.8170 | dividendYield: | 2.6941 |
| bookValuePerShare: | 18.1431 | marketCap: | 263835915095.3100 |
| earningsYield: | 5.5133 | pegRatio: | 1.6420 |
| cashFlowPerShare: | 7.5219 | netAssetsPerShare: | 18.1431 |
| priceBookValueRatio: | 5.7283 | priceEarningsRatio: | 18.1718 |
| netEarningsPerShare: | 5.7193 | currency: | USD |
Finanzen (ausführlich)
| year: | 2021 |
| units: | 1000000 |
| balanceSheetTotal: | 105694.0000 |
| cash: | 8096.0000 |
| currentAssets: | 30266.0000 |
| fixedAssets: | 75428.0000 |
| liabilities: | 23872.0000 |
| totalLiabilitiesEquity: | 105694.0000 |
| provisions: | 3441.0000 |
| totalShareholdersEquity: | 38257.0000 |
| employees: | 68000 |
| property: | 19279.0000 |
| intangibleAssets: | 22933.0000 |
| longTermInvestments: | 370.0000 |
| inventories: | 5953.0000 |
| accountsReceivable: | 9230.0000 |
| accountsPayable: | 4609.0000 |
| liabilitiesBanks: | 1768.0000 |
| liabilitiesTotal: | 67437.0000 |
| longTermDebt: | 30690.0000 |
| shortTermDebt: | 2412.0000 |
| minorityInterests: | 73.0000 |
| sales: | 48704.0000 |
| netIncome: | 13049.0000 |
| incomeInterest: | -1341.0000 |
| investments: | 12245.0000 |
| incomeTaxes: | 1521.0000 |
| costGoodsSold: | 13626.0000 |
| grossProfit: | 35078.0000 |
| minorityInterestsProfit: | 13.0000 |
| revenuePerEmployee: | 716235.2941 |
| cashFlow: | 13122.0000 |
| cashFlowInvesting: | -16421.0000 |
| cashFlowFinancing: | 3097.0000 |
| cashFlowTotal: | 14.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 36.1960 |
| debtEquityRatio: | 176.2736 |
| liquidityI: | 33.9142 |
| liquidityII: | 72.5788 |
| netMargin: | 26.7925 |
| grossMargin: | 72.0228 |
| cashFlowMargin: | 26.9423 |
| ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 36.2783 |
| preTaxROA: | 13.1313 |
| roe: | 34.1088 |
| roa: | 12.3460 |
| netIncomeGrowth: | 84.6470 |
| revenuesGrowth: | 1.4794 |
| taxExpenseRate: | 10.9590 |
| equityTurnover: | 1.2731 |
| epsBasic: | 5.1600 |
| epsDiluted: | 5.1400 |
| epsBasicGrowth: | 84.9462 |
| incomeBeforeTaxes: | 13879.0000 |
| priceEarningsRatioCompany: | 14.8527 |
| priceCashFlowRatio: | 14.7634 |
| dividendYield: | 3.4447 |
| bookValuePerShare: | 15.1349 |
| marketCap: | 193725503563.8400 |
| earningsYield: | 6.7328 |
| pegRatio: | 0.1748 |
| cashFlowPerShare: | 5.1912 |
| netAssetsPerShare: | 15.1638 |
| priceBookValueRatio: | 5.0638 |
| dividendsPerShare: | 2.6400 |
| priceEarningsRatio: | 14.8460 |
| netEarningsPerShare: | 5.1623 |
| currency: | USD |
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 109160.0000 |
| cash: | 12694.0000 |
| currentAssets: | 35722.0000 |
| fixedAssets: | 73438.0000 |
| liabilities: | 24239.0000 |
| totalLiabilitiesEquity: | 109160.0000 |
| totalShareholdersEquity: | 46058.0000 |
| property: | 21422.0000 |
| intangibleAssets: | 20269.0000 |
| longTermInvestments: | 1015.0000 |
| inventories: | 5911.0000 |
| accountsReceivable: | 9450.0000 |
| accountsPayable: | 4264.0000 |
| liabilitiesTotal: | 63102.0000 |
| longTermDebt: | 28745.0000 |
| shortTermDebt: | 1946.0000 |
| minorityInterests: | 67.0000 |
| sales: | 59283.0000 |
| netIncome: | 14519.0000 |
| incomeInterest: | 1501.0000 |
| investments: | 13548.0000 |
| incomeTaxes: | 1918.0000 |
| costGoodsSold: | 17411.0000 |
| grossProfit: | 41872.0000 |
| minorityInterestsProfit: | 7.0000 |
| cashFlow: | 19095.0000 |
| cashFlowInvesting: | -4960.0000 |
| cashFlowFinancing: | -9119.0000 |
| cashFlowTotal: | 4606.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 42.1931 |
| debtEquityRatio: | 137.0055 |
| liquidityI: | 52.3701 |
| liquidityII: | 91.3569 |
| netMargin: | 24.4910 |
| grossMargin: | 70.6307 |
| cashFlowMargin: | 32.2099 |
| ebitMargin: | 0.0000 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 35.7028 |
| preTaxROA: | 15.0641 |
| roe: | 31.5233 |
| roa: | 13.3007 |
| netIncomeGrowth: | 11.2652 |
| revenuesGrowth: | 21.7210 |
| taxExpenseRate: | 11.6638 |
| equityTurnover: | 1.2871 |
| epsBasic: | 5.7300 |
| epsDiluted: | 5.7100 |
| epsBasicGrowth: | 11.0465 |
| incomeBeforeTaxes: | 16444.0000 |
| priceEarningsRatioCompany: | 19.3630 |
| priceCashFlowRatio: | 14.7503 |
| dividendYield: | 2.5237 |
| bookValuePerShare: | 18.1431 |
| marketCap: | 281656834213.6500 |
| earningsYield: | 5.1645 |
| pegRatio: | 1.7529 |
| cashFlowPerShare: | 7.5219 |
| netAssetsPerShare: | 18.1695 |
| priceBookValueRatio: | 6.1153 |
| dividendsPerShare: | 2.8000 |
| priceEarningsRatio: | 19.3992 |
| netEarningsPerShare: | 5.7193 |
| currency: | USD |
| year: | 2023 |
| priceEarningsRatioCompany: | 18.1379 |
| priceCashFlowRatio: | 13.8170 |
| dividendYield: | 2.6941 |
| bookValuePerShare: | 18.1431 |
| marketCap: | 263835915095.3100 |
| earningsYield: | 5.5133 |
| pegRatio: | 1.6420 |
| cashFlowPerShare: | 7.5219 |
| netAssetsPerShare: | 18.1431 |
| priceBookValueRatio: | 5.7283 |
| priceEarningsRatio: | 18.1718 |
| netEarningsPerShare: | 5.7193 |
| currency: | USD |
